The Global LDL Test Marketis expected to grow with a CAGR of approximately 5.5% during the forecast period from 2017-2023.
LDL is also mentioned as bad cholesterol since high levels of LDL results in cholesterol build-up which may lead to heart attack and strokes. LDL is one of the five major types of lipoproteins and other four are chylomicrons, very low-density lipoprotein (VLDL), intermediate-density lipoprotein (IDL), low-density lipoprotein (LDL) and high-density lipoprotein (HDL). The major role of lipoprotein particles is to transport fats such as triglycerides and cholesterol in the blood between the organs of the body.
According to Centres for Disease Control and Prevention, (2015) 71 million American adults have high low-density lipoprotein (LDL), or bad cholesterol level. Only 2 out of every 3 adults with LDL cholesterol has the condition under control.
Get a Sample Copy of This Report @ https://www.marketresearchfuture.com/sample_request/4215 .
The market drivers for LDL market are increasing geriatric population, increasing obese and overweight population. The major market restraints for this test are risks associated with this such as excessive bleeding and infection during multiple puncture wounds, low healthcare expenditure in developing regions which may hamper the market growth.
Global LDL Test Market – Competitive Analysis
Hoffmann-La Roche Ltd (Switzerland), Sekisui Diagnostics (U.S.), Express Biotech International (U.S.), Sigma-Aldrich Co. LLC. (U.S.), Randox Laboratories Ltd (Ireland), Reckon Diagnostics (India), Quest Diagnostics Incorporated (U.S.), DiaSys Diagnostics India Private Limited (India), Eurofins Scientific (Germany), Kopibeskyttet Unilabs Labhåndbok (UK), Atlas Medical Uk (UK), Eurolyser Diagnostica GmbH (Germany), Laboratory Corporation of America, Diazyme Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and others are some of the prominent players at the forefront of competition in the global LDL test market and are profiled in MRFR Analysis.
Geographically, the global LDT test market is segmented into Americas, Europe, Asia Pacific and the Middle East & Africa. The Americas account for a significant market share owing to extensive use of medications, high expenditure on the health care, huge patient population and increasing government support for research & development. Also, major research and manufacturing companies are present in America.
Europe is the second largest market in the world due to high income, government support for research & development and availability of resources.
Asia Pacific region shows the fastest growth owing to the presence of huge population base, and continuous development in the healthcare sector. China and India are likely to lead this market due to fast growing healthcare sector during the forecasted period.
Get Attractive Discount on This Report @ https://www.marketresearchfuture.com/check-discount/4215 .
On the other hand, the Middle East & Africa has the least market share due to limited development in the healthcare sector. Middle East holds a major share for the market due to presence of gulf nations such as Saudi Arabia and the UAE. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development.
1 Report Prologue
2 Market Introduction
2.2 Scope of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.5 Market Structure
3 Research Methodology
3.1 Primary Research Methodology
3.2 Secondary Research Methodology
3.3 Market Share Analysis
3.4 Market Pricing Approach
4 Market Factor Analysis
Inquire about This Report @ https://www.marketresearchfuture.com/enquiry/4215 .
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
+1 646 845 9312